A Randomized Controlled Double-Blind Clinical Trial of 17-Hydroxyprogesterone Caproate for the Prevention of Preterm Birth in Twin Gestation (PROGESTWIN): Evidence for Reduced Neonatal Morbidity

    loading  Checking for direct PDF access through Ovid

Abstract

(BJOG. 2015;122(1):71–79)

Related Topics

    loading  Loading Related Articles